These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 26289642)

  • 1. The forkhead transcription factor FOXP1 represses human plasma cell differentiation.
    van Keimpema M; Grüneberg LJ; Mokry M; van Boxtel R; van Zelm MC; Coffer P; Pals ST; Spaargaren M
    Blood; 2015 Oct; 126(18):2098-109. PubMed ID: 26289642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The small FOXP1 isoform predominantly expressed in activated B cell-like diffuse large B-cell lymphoma and full-length FOXP1 exert similar oncogenic and transcriptional activity in human B cells.
    van Keimpema M; Grüneberg LJ; Schilder-Tol EJ; Oud ME; Beuling EA; Hensbergen PJ; de Jong J; Pals ST; Spaargaren M
    Haematologica; 2017 Mar; 102(3):573-583. PubMed ID: 27909217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of FOXP1 is required during germinal center B-cell function.
    Sagardoy A; Martinez-Ferrandis JI; Roa S; Bunting KL; Aznar MA; Elemento O; Shaknovich R; Fontán L; Fresquet V; Perez-Roger I; Robles EF; De Smedt L; Sagaert X; Melnick A; Martinez-Climent JA
    Blood; 2013 May; 121(21):4311-20. PubMed ID: 23580662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXP1 directly represses transcription of proapoptotic genes and cooperates with NF-κB to promote survival of human B cells.
    van Keimpema M; Grüneberg LJ; Mokry M; van Boxtel R; Koster J; Coffer PJ; Pals ST; Spaargaren M
    Blood; 2014 Nov; 124(23):3431-40. PubMed ID: 25267198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells.
    Brown PJ; Gascoyne DM; Lyne L; Spearman H; Felce SL; McFadden N; Chakravarty P; Barrans S; Lynham S; Calado DP; Ward M; Banham AH
    Haematologica; 2016 Jul; 101(7):861-71. PubMed ID: 27056922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma.
    Vogel MJ; Xie L; Guan H; Tooze RM; Maier T; Kostezka U; Maier HJ; Holzmann K; Chan FC; Steidl C; Reichel JB; Weitzer CD; Gehringer F; Kick AB; Cesarman E; Roshal M; Gascoyne RD; Möller P; Wirth T; Ushmorov A
    Blood; 2014 Nov; 124(20):3118-29. PubMed ID: 25232062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXP1 inhibits plasma cell differentiation.
    Toellner KM
    Blood; 2015 Oct; 126(18):2076-7. PubMed ID: 26516214
    [No Abstract]   [Full Text] [Related]  

  • 8. The hematopoietic oncoprotein FOXP1 promotes tumor cell survival in diffuse large B-cell lymphoma by repressing S1PR2 signaling.
    Flori M; Schmid CA; Sumrall ET; Tzankov A; Law CW; Robinson MD; Müller A
    Blood; 2016 Mar; 127(11):1438-48. PubMed ID: 26729899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of the FOXP1 Transcription Factor Leads to Deregulation of B Lymphocyte Development and Function at Multiple Stages.
    Dekker JD; Baracho GV; Zhu Z; Ippolito GC; Schmitz RJ; Rickert RC; Tucker HO
    Immunohorizons; 2019 Oct; 3(10):447-462. PubMed ID: 31591252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXP1 is a regulator of quiescence in healthy human CD4
    Garaud S; Roufosse F; De Silva P; Gu-Trantien C; Lodewyckx JN; Duvillier H; Dedeurwaerder S; Bizet M; Defrance M; Fuks F; Bex F; Willard-Gallo K
    Eur J Immunol; 2017 Jan; 47(1):168-179. PubMed ID: 27861791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1.
    Dekker JD; Park D; Shaffer AL; Kohlhammer H; Deng W; Lee BK; Ippolito GC; Georgiou G; Iyer VR; Staudt LM; Tucker HO
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):E577-86. PubMed ID: 26787899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells.
    Teng Y; Takahashi Y; Yamada M; Kurosu T; Koyama T; Miura O; Miki T
    Eur J Cell Biol; 2007 Oct; 86(10):581-9. PubMed ID: 17651861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas.
    Brown PJ; Wong KK; Felce SL; Lyne L; Spearman H; Soilleux EJ; Pedersen LM; Møller MB; Green TM; Gascoyne DM; Banham AH
    Leukemia; 2016 Mar; 30(3):605-16. PubMed ID: 26500140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forkhead box protein P1 expression in mucosa-associated lymphoid tissue lymphomas predicts poor prognosis and transformation to diffuse large B-cell lymphoma.
    Sagaert X; de Paepe P; Libbrecht L; Vanhentenrijk V; Verhoef G; Thomas J; Wlodarska I; De Wolf-Peeters C
    J Clin Oncol; 2006 Jun; 24(16):2490-7. PubMed ID: 16636337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures.
    Wong KK; Gascoyne DM; Soilleux EJ; Lyne L; Spearman H; Roncador G; Pedersen LM; Møller MB; Green TM; Banham AH
    Oncotarget; 2016 Aug; 7(33):52940-52956. PubMed ID: 27224915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1.
    Rao DS; O'Connell RM; Chaudhuri AA; Garcia-Flores Y; Geiger TL; Baltimore D
    Immunity; 2010 Jul; 33(1):48-59. PubMed ID: 20598588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXP1 expression in monoclonal gammopathy of undetermined significance and multiple myeloma.
    Korać P; Peran I; Skrtić A; Ajduković R; Kristo DR; Dominis M
    Pathol Int; 2009 May; 59(5):354-8. PubMed ID: 19432679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of FOXP1 in diffuse large B-cell lymphoma.
    Gascoyne DM; Banham AH
    Leuk Lymphoma; 2017 May; 58(5):1037-1051. PubMed ID: 27678023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL.
    Brown PJ; Ashe SL; Leich E; Burek C; Barrans S; Fenton JA; Jack AS; Pulford K; Rosenwald A; Banham AH
    Blood; 2008 Mar; 111(5):2816-24. PubMed ID: 18077790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancer.
    De Silva P; Garaud S; Solinas C; de Wind A; Van den Eyden G; Jose V; Gu-Trantien C; Migliori E; Boisson A; Naveaux C; Duvillier H; Craciun L; Larsimont D; Piccart-Gebhart M; Willard-Gallo K
    EBioMedicine; 2019 Jan; 39():226-238. PubMed ID: 30579865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.